GMEDGlobus Medical, Inc.

$12B

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$626M+63.1% YoY

Gross Profit

$355M56.8% margin

Operating Income

$48M7.7% margin

Net Income

$52M8.3% margin

EPS (Diluted)

$0.38

QoQ Revenue Growth

-0.6%

Cash Flow

Operating Cash Flow

$204M

Free Cash Flow

$162M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$5.1B

Total Liabilities

$1.0B

Stockholders' Equity

$4.1B

Cash & Equivalents

$623M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$626M	$384M	+63.1%
Gross Profit	$355M	$248M	+43.1%
Operating Income	$48M	$404,000	+11805.4%
Net Income	$52M	$998,000	+5094.0%

Revenue Segments

Spine

$587M94%

Emerging Technology

$38M6%

Geographic Segments

UNITED STATES

$496M79%

Non Us

$130M21%

GMED Q3 2024 Earnings — Globus Medical, Inc. Revenue & Financial Results | Market Cap Arena